Skip to main content
. 2017 Dec 2;8(1):8–21. doi: 10.1016/j.ijpddr.2017.11.004

Table 1.

Named compounds that were active in the C. elegans growth screen. Log2-fold change in growth estimate compared to DMSO-only controls. Hit ID is as in Fig. 7B. EC50 confidence interval is the standard error. The EC50 estimate for mebendazole is from Fig. 3. Primary and secondary screens used solutions supplied as part of the Pathogen Box Library. EC50 estimates were determined using solid material.

Compound MMV ID PubChem CID Hit ID Log2 fold change in growth
EC50 (μM) ± standard error
(1° screen) (2° screen) (solid material)
Tolfenpyrad MMV688934 10,110,536 1 −10.9 −10.6 0.2 ± 0.04
Auranofin MMV688978 24,199,313 2 −10.9 −7.2 1.1 ± 0.3
Mebendazole MMV003152 4030 5 −6.0 −5.7 1.1 ± 0.2
Isradipine MMV001493 158,617 16 −2.2 −1.4 1.6 ± 0.7
Tavaborole n/a 11,499,245 n/a n/a 8.6 ± 1.9